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This data article contains complementary ﬁgures and results
related to the research article entitled, “Cellular localization of iron
(II) polypyridyl complexes determines their anticancer action
mechanisms” [1] (Chen et al., 2015).
The characterization of Fe(II) complexes by ESI-MS, 1H NMR, 13C
NMR spectroscopy, FT-IR spectra, UV–vis spectra was provided. Also,
the data for the stability of Fe(II) complexes 1–5 in DMSO/Milli-Q
water/ culture medium (without serum or phenol red) at 37 °C at
different periods of time by UV–vis spectra and 1H NMR was showed.
At the same time, the anticancer efﬁcacy, cellular distribution and ROS
generation in MCF-7 cells of complexes are reported. In addition, we
also show the cellular localization of complex 4, the relative ﬂuores-
cence intensity of complex 1 and complex 3 pretreated with anti-TfR
(2 μg/mL) in MCF-7 cells using ﬂow cytometry. The compilation of this
data provides an invaluable resource for the wider research commu-
nity and the interpretation of these data could be found in the research
article noted above.
& 2016 Published by Elsevier Inc. This is an open access article under
the CC BY license (http://creativecommons.org/licenses/by/4.0/).is an open access article under the CC BY license
/j.biomaterials.2015.08.031
ﬁrst authors.
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Dubject area Chemistry
ore speciﬁc sub-
ject areaMetal complexes, cellular localization, anticancer mechanismype of data Table, image, graph, ﬁgure
ow data was
acquiredNMR, mass spectroscopy,UV–vis, FT-IR, MTT assay, ﬂuorescence microscope, ﬂow
cytometry, DHE assay.ata format Raw, analyzed
xperimental
factorsThe stability of the Fe(II) complexes was carried out at 37 °C; MCF-7 cells were
exposed to the different concentrations of the Fe(II) complexes for different
periods of time and analyzed by MTT assay; cells were treated with complex 4
and examined under ﬂuorescence microscope; MCF-7 cells were treated with Fe
(II) complexes and analysis its distribution; MCF-7 cells pretreated with anti-TfR,
and then Fe(II) complexes were added and sequentially incubated in CO2 incu-
bator, the results were analyzed by ﬂow cytometry; MCF-7 cells harvested by
centrifugation and resuspended in PBS were incubated with DHE, then the cells
were incubated with different concentrations of complexes for different periods
of time.xperimental
featuresThe characterization of the complexes was analyzed by ESI-MS, 1H NMR, 13C
NMR spectroscopy, FT-IR spectra, UV–vis spectra; the stability of the Fe(II)
complexes was carried out by1H NMR and UV–vis spectra; the anticancer efﬁ-
cacy was carried out by MTT assay; the cellular localization of complex 4 in
MCF-7, A375 and HeLa was examined under ﬂuorescence microscope; the cel-
lular distribution of Fe complexes was analysis by ﬂuorescence intensity; the
relative ﬂuorescence intensity of complex 1 and complex 3 pretreated with anti-
TfR (2 μg/mL) in MCF-7 cells were analyzed by ﬂow cytometry; the ROS gen-
eration in MCF-7 cells of complexes was measured by DHE assay.ata source
locationGuangzhou, Chinaata accessibility All data provided within this articleValue of the data
 Data on ESI-MS, 1H NMR, 13C NMR spectroscopy, FT-IR spectra and UV–vis spectra were provided
for the characterization of Fe(II) complexes, which provides an invaluable resource for the wider
research community.
 Data on UV–vis spectra and 1H NMR in DMSO, aqueous media and culture medium during incu-
bation at 37 °C within 72 h, which show the complexes are stable once internalized by the cells,
opening up doors for new collaborations.
 Data on anticancer efﬁcacy, cellular ROS levels, cellular distribution and cellular localization of
complexes was provided, which was available for other researchers using this data as a benchmark.1. Data
In this article we share the synthesis and characterization of Fe(II) complexes 1–5 that exhibit
potent anticancer activities [1]. The stability, cytotoxicity, intracellular ROS generation levels, cellular
distribution, cellular localization and relative ﬂuorescence intensity of complexes were shown See
Table 1 and Figs. 1–24.
Fig. 1. The ESI-MS of complexes 1–5.
Table 1
The ESI-MS analysis of complexes 1–5.
Complexes Theoretical value (m/z) Measured value (m/z) Belonging to (m/z)
1 262.07 261.9 ½M  2ðClO4 Þ2þ
2 298.07 298.07 ½M  2ðClO4 Þ2þ
3 358.08 358.4 ½M  ðSO24 Þ2þ
4 472.12 472.0 ½M  ðSO24 Þ2þ
5 493.15 493.4 ½M  ðSO24 Þ2þ
a,a’ b,b’
c,c’
d,d’
Fig. 2. 1H NMR spectrum (500 MHz) of complex 1 in dimethylsulfoxide-d6.
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a,a’
c,c’
b,b’,c,c’
Fig. 3. 1H NMR spectrum (500 MHz) of complex 2 in dimethylsulfoxide-d6.
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c,c’
b,b’d
Fig. 4. 1H NMR spectrum (500 MHz) of complex 3 in dimethylsulfoxide-d6.
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c,c’a,a’
g
Fig. 5. 1H NMR spectrum (500 MHz) of complex 4 in dimethylsulfoxide-d6.
d,d’
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a,a’
g
e,e’f
Fig. 6. 1H NMR spectrum (500 MHz) of complex 5 in dimethylsulfoxide-d6.
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e,e’ a,a’ c,c’ d,d’ b,b’
Fig. 7. 13C NMR spectrum (300 MHz) of complex 1 in dimethylsulfoxide-d6.
e,e’a,a’ c,c’
d,d’
b,b’f,f’
Fig. 8. 13C NMR spectrum (300 MHz) of complex 2 in dimethylsulfoxide-d6.
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Fig. 9. 13C NMR spectrum (300 MHz) of complex 3 dimethylsulfoxide-d6.
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Fig. 10. UV–visible spectrum of the Fe(II) complexes 1–5 in 5 mM Tris–HCl buffer (pH¼7.2).
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Fig. 11. FT-IR spectrum of the Fe(II) complexes 1–5 in KBr phase.
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Fig. 12. The stability of Fe(II) complexes 1–5 in DMSO during incubation at 37 °C within 72 h. (A) 1, (B) 2, (C) 3, (D) 4, (E) 5.
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Fig. 13. The stability of Fe(II) complexes 1–5 in H2O during incubation at 37 °C within 72 h. (A) 1, (B) 2, (C) 3, (D) 4, (E) 5.
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Fig. 14. The stability of Fe(II) complexes 1–5 in DMEM during incubation at 37 °C within 72 h. (A) 1, (B) 2, (C) 3, (D) 4, (E) 5.
Fig. 15. 1H NMR spectrum (300 MHz) of complex 1 in deuterium oxide within 72 h.
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Fig. 16. 1H NMR spectrum (300 MHz) of complex 2 in deuterium oxide within 72 h.
J. Chen et al. / Data in Brief 8 (2016) 670–686 679
Fig. 17. 1H NMR spectrum (300 MHz) of complex 3 in deuterium oxide within 72 h.
J. Chen et al. / Data in Brief 8 (2016) 670–686680
Fig. 18. 1H NMR spectrum (300 MHz) of complex 4 in deuterium oxide within 72 h.
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Fig. 19. 1H NMR spectrum (300 MHz) of complex 5 in deuterium oxide within 72 h.
J. Chen et al. / Data in Brief 8 (2016) 670–686682
Fig. 20. The time- and dose-dependent cytotoxicity of Fe(II) complexes 1–5. MCF-7 cells were exposed to the different con-
centrations of the Fe(II) complexes 1–5 for 24 h, 36 h, 72 h.
Fig. 21. The cellular localization of complex 4 in MCF-7, A375 and HeLa cells respectively. Cells were treated with 32 μM of
complex 4 for 24 h and examined under ﬂuorescence microscope.
J. Chen et al. / Data in Brief 8 (2016) 670–686 683
Fig. 23. The intracellular ROS generation levels in MCF-7 cells by complexes 1–5 using DHE assay.(A) complex 1, (B) complex 2,
(C) complex 3, (D) complex 4 and (E) complex 5.
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Fig. 22. The distribution of Fe complexes (A) 1, (B) 3 in MCF-7 cells. MCF-7 cells were treated with 32 μM of Fe(II) complexes
for 24 h respectively.
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Fig. 24. Relative ﬂuorescence intensity of (A) complex 1 (32 μM, 12 h) and (B) complex 3 (32 μM, 12 h) pretreated with anti-TfR
(2 μg/mL, 2 h) in MCF-7 cells using ﬂow cytometry.
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2.1. Methods
2.1.1. The characterization of the Fe(II) complexes 1 and 2
Synthesis of Fe(bpy)3(ClO4)2 (1) and Fe(phen)3(ClO4)2 (2). The Fe(II) complexes 1–2 were synthesized
according to published procedures [2]. Fe(bpy)3(ClO4)2 (1) Yield 85%. ESI-MS: m/z 261.9 [M-2
(ClO4)]2þ . Elemental analysis calc (%) for C30H24Cl2N6O8Fe: C, 49.82; H, 3.34; N, 11.62; found (%):
C, 49.76; H, 3.28; N, 15.50. UV–vis (λ (nm), ε/104 (M1 cm1): 295 (6.3), 518 (0.66). IR (KBr): ν 3090
(N-H), ν 1610, 1440 (C¼C arom) cm1. 1H NMR (DMSO-d6, δ ppm): 8.87 (d, 6H), 8.22 (t, 6H), 7.53 (t,
6H), 7.42 (d, 6H). 13C NMR (DMSO-d6, δ ppm): 159.21 (s, 6C), 154.12 (s, 6C), 139.07 (s, 6C), 128.03 (s,
6C), 124.57(s, 6C).
Fe(phen)3(ClO4)2 (2) Yield 90%. ESI-MS: m/z 298.07 [M-2(ClO4)]2þ . Elemental analysis calc (%)
for C36H24Cl2N6O8Fe: C, 54.36; H, 3.04; N, 10.57; found (%): C, 54.30; H, 2.97; N, 10.51. UV–vis (λ (nm),
ε/104 (M1 cm1): 264 (9.47), 511 (0.98). IR (KBr): ν 3060 (N–H), ν 1630, 1425 (C¼Carom) cm1. 1H
NMR (DMSO-d6, δ ppm): 8.81 (d, 6H), 8.41 (s, 6H), 7.75 (t, 6H), 7.72 (d, 6H). 13C NMR (DMSO-d6, δ
ppm): 156.53 (s, 6C), 149.87 (s, 6C), 137.97 (s, 6C), 130.32 (s, 6C), 128.83(s, 6C), 126.91(s, 6C).2.1.2. Stability of Fe(II) complexes
The stability of the Fe(II) complexes in DMSO, aqueous media, culture medium were examined by
UV–vis spectrometry using a Cary 5000 UV-2450 spectropho-tometer. Spectra was collected from
samples dissolved in DMSO/Milli-Q water/ culture medium (without serum or phenol red). Each
spectrum (230–600 nm) was recorded after incubation of the sample in DMSO/Milli-Q water/ culture
medium (without serum or phenol red) at 37 °C at different periods of time.
The stability of the Fe(II) complexes in aqueous media was also examined by.
1H NMR (Bruker, 300 MHz). Nuclear magnetic resonance spectroscopy was collected from samples
dissolved in deuteroxide. Each spectrum was recorded after incubation of the sample in deuteroxide
at different periods of time.
J. Chen et al. / Data in Brief 8 (2016) 670–6866862.1.3. Examination the distribution of Fe complexes in MCF-7 cells
MCF-7 cells were treated with 32 μM of Fe(II) complexes for 24 h respectively, and separated the
nucleus by Nuclei PURE Prep (NUC201-1KT). The collected fractions were then subjected to ﬂuores-
cence determination.
2.1.4. Measurement of ROS generation
The intracellular ROS generation levels in MCF-7 cells by complexes 1–5 were measured by DHE
assay as reported [3]. ROS generation was measured by the ﬂuorescence intensity on a Tecan SAFIRE
ﬂuorescence reader, the excitation and emission wavelengths were 300 and 610 nm. Relative DHE
ﬂuorescence intensity of treated cells was expressed as percentage of control (as 100%).Acknowledgments
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